Simplex Trading, LLC Passage Bio, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$0.6 - $1.01 $1,253 - $2,109	2,089 New	2,089 $2,000
Q1 2023 Apr 27, 2023	BUY	$0.96 - $1.88 $305 - $597	318 New	318 $0
Q2 2022 Aug 03, 2022	SELL	$1.63 - $3.46 $1,160 - $2,463	-712 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$2.66 - $6.49 $332 - $811	125 Added 21.29%	712 $2,000
Q3 2021 Oct 28, 2021	BUY	$9.73 - $15.52 $1,946 - $3,104	200 Added 51.68%	587 $8,000
Q2 2021 Aug 12, 2021	BUY	$12.44 - $19.45 $3,383 - $5,290	272 Added 236.52%	387 $5,000
Q1 2021 Apr 26, 2021	BUY	$16.24 - $29.83 $1,867 - $3,430	115 New	115 $2,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.